Triple
T10292258
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Genmab |
E241390
|
entity |
| Predicate | collaboratesWith |
P37
|
FINISHED |
| Object |
Seagen
Seagen is a biotechnology company specializing in the development of antibody-drug conjugate (ADC) therapies for cancer treatment.
|
E854988
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d381aaafc08190af475ef58dc16aba |
elicitation | completed |
| NER | batch_69d4d2d35f048190a215493acdf1f718 |
ner | completed |
| NED1 | batch_69d71d1465e88190aaa8b295df3f9c8c |
ned_source_triple | completed |
| NED2 | batch_69d7326b14988190bff33dc01e690707 |
ned_description | completed |
| NEDg | batch_69d73180d90481908f1b4768230edd36 |
nedg | completed |
Created at: April 6, 2026, 11:42 a.m.